| Literature DB >> 35535036 |
Shengtao Wang1, Yan Li1, Ximei Wang1, Yuanyuan Zhang2, Yiyi Yuan3, Yong Li1.
Abstract
The coronavirus disease (COVID-19) which emerged in Wuhan, China, in December 2019, is widely controlled now in China. However, the global epidemic is still severe. To study and comment on Hubei's approaches for responding to the disease, the paper considered some factors such as suspected cases (part of them are influenza patients or common pneumonia patients, etc.), quarantine, patient classification (three types), clinically diagnosed cases, and lockdown of Wuhan and Hubei. After that, the paper established an SELIHR model based on the surveillance data of Hubei published by the Hubei Health Commission from 10 January 2020 to 30 April 2020 and used the fminsearch optimization method to estimate the optimal parameters of the model. We obtained the basic reproduction number ℛ 0 = 3.1571 from 10 to 22 January. ℛ 0 was calculated as 2.0471 from 23 to 27 January. From 28 January to 30 April, ℛ 0 = 1.5014. Through analysis, it is not hard to find that the patients without classification during the period of confirmed cases will result in the cumulative number of cases in Hubei to increase. In addition, regarding the lockdown measures implemented by Hubei during the epidemic, our simulations also show that if the lockdown time of either Hubei or Wuhan is advanced, it will effectively curb the spread of the epidemic. If the lockdown measures are not taken, the total cumulative number of cases will increase substantially. From the results of the study, it can be concluded that the lockdown, patient classification, and the large-scale case screening are essential to slow the spread of COVID-19, which can provide references for other countries or regions.Entities:
Mesh:
Year: 2022 PMID: 35535036 PMCID: PMC9077452 DOI: 10.1155/2022/8920117
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
The results of ℛ0 in Wuhan, Hubei or China.
| Area | Research time | Value (95% or 90% CI) | Resources |
|---|---|---|---|
| China | Jan. 22, 2020-Mar. 30, 2020 | 0.454 | Collins and Duffy [ |
| Wuhan | Feb. 2, 2020-Feb. 11, 2020 | 0.84 (0.81-0.88) | Mizumoto et al. [ |
| Wuhan | Jan. 4, 2020-Mar. 9, 2020 | 0.945 | Ndaïrou et al. [ |
| China | Jan. 24, 2020-Feb. 8, 2020 | 0.99 (0.76-1.33) | Li et al. [ |
| Wuhan | Feb. 4, 2020-Feb. 12, 2020 | 1.08 | Zhang et al. [ |
| Wuhan | Jan. 23, 2020-Feb. 1, 2020 | 1.3065 (0.5273-2.0858) | Xue et al. [ |
| Wuhan | Jan. 21, 2020-Feb. 8, 2020 | 1.32 (1.16-1.48) | Du et al. [ |
| Wuhan | Jan. 15, 2020-Feb. 4, 2020 | 1.3469, 2.8349 | Sun et al. [ |
| China | Jan. 24, 2020-Feb. 3, 2020 | 1.36 (1.14-1.63) | Li et al. [ |
| China | Jan. 18, 2020 | 1.40-2.50 | WHO [ |
| Wuhan | Jan. 23, 2020-Feb. 3, 2020 | 1.55 | Zhang et al. [ |
| Wuhan | Jan. 24, 2020-Feb. 11, 2020 | 1.7549 | Pang et al. [ |
| Wuhan | Jan. 25, 2020 | 2.00-3.00 | Abbott et al. [ |
| China | Jan. 24, 2020 | 2.10 (2.00-2.20) | Jung et al. [ |
| China and overseas | Jan. 18, 2020 | 2.20 (90% HDI 1.40-3.80) | Riou and Althaus. [ |
| Wuhan | Before Jan. 22, 2020 | 2.20 (1.40-3.90) | Li et al. [ |
| Wuhan | Jan. 10, 2020-Jan. 24, 2020 | 2.24 (1.96-2.55) | Zhao et al. [ |
| Wuhan | Jan. 10, 2020-Jan. 23, 2020 | 2.38 (2.03-2.77) | Li et al. [ |
| Wuhan | Dec. 10, 2019-Jan. 21, 2020 | 2.42 | Hu et al. [ |
| Wuhan | Jan. 1, 2020-Jan. 15, 2020 | 2.56 (2.49-2.63) | Zhao et al. [ |
| Wuhan | Jan. 23, 2020 | 2.57 (90% CI 2.37-2.78) | Chinazzi et al. [ |
| China | Jan. 20, 2020-Feb. 11, 2020 | 2.68 | Liu et al. [ |
| Wuhan | Dec. 31, 2019-Jan. 25, 2020 | 2.68 (2.47-2.86) | Wu et al. [ |
| Wuhan | Jan. 18, 2020-Feb. 13, 2020 | 2.70 | Guo et al. [ |
| Wuhan | Jan. 23, 2020-Mar. 6, 2020 | 2.71 | Wang et al. [ |
| Wuhan | Dec. 22, 2019-Mar. 15, 2020 | 2.80 | Musa et al. [ |
| China | Jan. 25, 2020 | 2.80-3.30 | Zhou et al. [ |
| Wuhan | Dec. 12, 2019-Feb. 22, 2020 | 3.04 | Huang et al. [ |
| Wuhan | Jan. 1, 2020-Jan. 22, 2020 | 3.11 (2.39-4.13) | Read et al. [ |
| China | Dec. 31, 2019-Jan. 23, 2020 | 3.15 (3.04-3.26) | Tian et al. [ |
| China | Jan. 24, 2020 | 3.20 (2.70-3.70) | Jung et al. [ |
| Wuhan | Jan. 24, 2020-Feb. 5, 2020 | 3.30 (2.66-3.95) | Ma et al. [ |
| China (excluding Hubei province) | Jan. 20, 2020-Mar. 3, 2020 | 3.36 (3.20-3.64) | Wan et al. [ |
| Wuhan | Jan. 11, 2020-Jan. 23, 2020 | 3.4074 (2.9959-3.8188) | Xue et al. [ |
| Wuhan | 2019-2020 | 3.49 (3.39-3.62) | Mizumoto et al. [ |
| Wuhan | Dec. 7, 2019-Jan. 1, 2020 | 3.58 | Chen et al. [ |
| Wuhan | Jan. 10, 2020-Jan. 24, 2020 | 3.58 (2.89-4.39) | Zhao et al. [ |
| Wuhan | Dec. 8, 2019-Jan. 22, 2020 | 3.6 | Zhang et al. [ |
| Wuhan | Jan. 26, 2020-Feb. 9, 2020 | 3.66 | Wang et al. [ |
| Hubei | Jan. 27, 2020-Feb. 11, 2020 | 3.7732 | Li et al. [ |
| Wuhan | Jan. 10, 2020-Jan. 30, 2020 | 4.30 | Song et al. [ |
| Wuhan | Dec. 31, 2019-Jan. 23, 2020 | 4.6355 | Pang et al. [ |
| Hubei | Jan. 11, 2020-Jan. 22, 2020 | 5.6015 | Li et al. [ |
| Hubei | Jan. 23, 2020-Feb. 19, 2020 | 5.6870, 2.2426, 1.0560 | Jia et al. [ |
| Wuhan | Jan. 15, 2020-Jan. 30, 2020 | 5.70 (3.80-8.90) | Sanche et al. [ |
| China | Jan. 10, 2020-Feb. 4, 2020 | 5.78 (5.71-5.89) | Wang et al. [ |
| China | Jan. 10, 2020-Jan. 22, 2020 | 6.47 (5.71-7.23) | Tang et al. [ |
| China | Jan. 23, 2020-Jan. 26, 2020 | 6.6037 | Li et al. [ |
| Wuhan | Jan. 4, 2020-Jan. 23, 2020 | 7.53 | Song et al. [ |
Figure 1Flow chart of compartments of the COVID-19 model.
Parameter estimates for COVID-19 model in Hubei.
| Parameter | Definitions | Value | Source |
|---|---|---|---|
|
| Transmission rate (day‐1individual‐1) | 1.8208 | Estimated |
|
| Transmission rate | 0.5487 | Estimated |
|
| Transmission rate | 1.1720 | Estimated |
|
| Transmission rate | 0.3648 | Estimated |
|
| Transmission rate | 0.8665 | Estimated |
|
| Transmission rate | 0.5643 | Estimated |
|
| Mortality rate of clinically diagnosed cases (day−1) | 3.8858 × 10−5 | Estimated |
|
| Mortality rate of mild patients (day−1) | 2.0436 × 10−4 | Estimated |
|
| Mortality rate of severely ill patients (day−1) | 4.5000 × 10−4 | Estimated |
|
| Mortality rate of critically ill patients (day−1) | 0.0641 | Estimated |
|
| Recovery rate of mild patients (day−1) | 0.2157 | Estimated |
|
| Recovery rate of severely ill patients (day−1) | 0.0606 | Estimated |
|
| Recovery rate of critically ill patients (day−1) | 0.0477 | Estimated |
|
| Self-healing ratio | 0.2117 | Estimated |
|
| Infectivity reduction factor | 0.0446 | Estimated |
|
| Infectivity reduction factor | 0.0259 | Estimated |
|
| Infectivity reduction factor | 0.0705 | Estimated |
|
| Infectivity reduction factor | 0.1561 | Estimated |
|
| Infectivity reduction factor | 0.2544 | Estimated |
|
| Infectivity reduction factor | 0.2282 | Estimated |
|
| System population reduction factor | 0.9700 | Estimated |
|
| Scale factor | 0.3000 | Estimated |
|
| Scale factor | 0.2499 | Estimated |
|
| Infectivity reduction factor | 0.0177 | Estimated |
|
| Infectivity reduction factor | 0.1364 | Estimated |
|
| Proportion of the infectious | 0.9984 | Estimated |
|
| Nucleic acid detection time (day−1) | 0.1472 | Estimated |
|
| Nucleic acid detection time | 0.1309 | Estimated |
|
| Nucleic acid detection time | 0.2576 | Estimated |
|
| Scale factor | 0.2411 | Estimated |
|
| Scale factor | 0.0786 | Estimated |
|
| Scale factor | 0.0246 | Estimated |
|
| Scale factor | 0.4870 | Estimated |
|
| System discharges | 8.8731 × 106 | Estimated |
|
| System discharges | 1.5910 × 107 | Estimated |
|
| Initial susceptible population | 3.1372 × 107 | Estimated |
|
| Initial exposed population | 2.2380 × 103 | Estimated |
|
| Initial suspected population | 55.5580 | Estimated |
|
| Initial clinically diagnosed cases | 497.9463 | Estimated |
|
| Initial mild patients | 5.7737 | Estimated |
|
| Initial critical patients | 11.0952 | Estimated |
Figure 2The cumulative reported and simulative cases in Hubei province (Y(t)).
Figure 3The severe cases and simulative cases in Hubei province (H2(t)).
Figure 4The critical cases and simulative cases in Hubei province (H3(t)).
Figure 5The death cases and simulative cases in Hubei province (D(t)).
The sensitivity indices of each parameter to the basic reproduction number.
| Parameter | Sensitivity index to | Percentage of corresponding change (%) |
|---|---|---|
|
| 0.9996 | −1.0004 |
|
| 0.4020 | −2.4877 |
|
| 0.0081 | −1.2392 × 102 |
|
| 0.0046 | −2.1799 × 102 |
|
| 0.0017 | −5.9956 × 102 |
|
| 0.0011 | −9.3002 × 102 |
|
| 8.2297 × 10−4 | −1.2151 × 103 |
|
| 4.6762 × 10−4 | −2.1385 × 103 |
|
| 2.1489 × 10−4 | −4.6535 × 104 |
|
| 1.0618 × 10−4 | −9.4181 × 103 |
|
| 1.4129 × 10−5 | −7.0778 × 103 |
|
| −0.5904 | 1.6937 |
|
| −0.4741 | 2.1093 |
|
| −0.4020 | 2.4877 |
|
| −0.0080 | 1.2463 × 102 |
|
| −0.0030 | 3.2885 × 102 |
|
| −6.7225 × 10−4 | 1.4875 × 103 |
|
| −3.1119 × 10−4 | 3.2134 × 103 |
|
| −1.5198 × 10−4 | 6.5799 × 103 |
Figure 6The comparison chart of the cumulative reported cases if the patient is not classified.
Figure 7The comparison chart of cumulative reported cases when discussing whether Wuhan and Hubei are locked down or not.
Figure 8The comparison chart of cumulative reported cases when Wuhan lockdown time remains unchanged, but Hubei lockdown time changed.
Figure 9The comparison chart of cumulative reported cases when Wuhan and Hubei are all locked down in advance or delayed.
Figure 10When the lockdown time of Wuhan and Hubei in which one is advanced and the other is delayed, the comparison chart of cumulative reported cases.
Figure 11The revised cumulative reported and simulative cases in Hubei province (Y(t)).